Category: clinical research

  • Decentralized Clinical Research Will Be A Paradigm-Shifting Trend

    Zeenia Framroze, Director of Strategy and Business Operations at Sharecare The field of clinical research is on the precipice of change, and for good reason. Traditional clinical trials and processes are primarily confined to sterile, isolated clinical settings that are often narrow in scope and provider-centric. Researchers of tomorrow, however, already are identifying accurate and […]

  • UK’s clinical research recovering slower than Euro peers, says ABPI

    The pandemic had a negative effect on clinical research across all countries, but the UK seems to be taking longer than others to recover, according to a report from the Association of the British Pharmaceutical Industry (ABPI). The industry body maintains however that the UK can bounce back strongly if it adopts the innovative approaches […]

  • AllStripes Secures $50M to Advance Global Rare Disease Research PlatforM

    Nancy Yu, CEO and Co-founder, AllStripes – AllStripes, a San Francisco-based healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, today announced it has raised $50 million in Series B funding led by Lux Capital, a current investor, joined by JAZZ Venture Partners, Spark Capital, Medidata Solutions, McKesson Ventures, and Maveron. The round also […]

  • Does draft RCT guide set the scene for future trials?

    A common set of standards for randomised clinical trials (RCTs) aims to help researchers develop the drugs and interventions of the future – no matter what they do or where they are based. The Good Clinical Trials Collaborative (GCTC) has published a draft guidance document, and is asking for the life sciences sector to make […]

  • Arcus’ CMO Grossman jumps ship to join Gilead’s cancer push

    Gilead Sciences just forged even closer ties with its cancer drug partner Arcus Biosciences, enticing the biotech’s chief medical officer Bill Grossman to a new role as its head of oncology clinical research. The two companies entered into a 10-year alliance last year, with Gilead claiming certain rights to Arcus clinical and preclinical immuno-oncology candidates […]

  • IQVIA adds to growing lab biz with $198M deal for Myriad contract services unit

    IQVIA is paying nearly $200 million to purchase a Myriad Genetics subsidiary that provides pharmaceutical contract services , a deal that will put the new acquisition in the company’s Q2 Solutions unit, The deal follows IQVIA’s April announcement that it had secured full ownership of Q2, which had been a joint venture with Quest Diagnostics.

  • Philips, Disney Partner to Improve Pediatric Experience During MRI Exams

    What You Should Know: – Philips and Walt Disney Company, today announced a partnership partners to conduct first of its kind clinical research pilot program that aims to help reduce fear and anxiety to improve children’s patient experience during MRI exams – As part of the partnership, Philips will investigate how Philips Ambient Experience – […]

  • Increasing patient engagement with UK clinical trials

    Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Patient engagement can help address long-running industry issues, such as recruitment and retention, as well as reducing the need for additional trial […]

  • Verily and Janssen Launch COVID-19 Immune Response Study

    What You Should Know: – Verily and Janssen launches COVID-19 Immune Response Study that aims to collect detailed information about how the coronavirus affects the immune system immediately after someone tests positive for COVID-19. Verily, an Alphabet company, is partnering with Janssen Research & Development LLC (Janssen) to launch a COVID-19 Immune Response Study as […]

  • Clinical research in 2021: A new era of collaboration and innovation

    The clinical research community has been disrupted in a number of ways due to COVID-19 and sparked a spirit of collaboration and innovation. Worldwide Clinical Trial’s Aman Khera gives five predictions of how clinical research could change in 2021. The pandemic has propelled the life science industry toward higher expectations for faster, more responsive and […]

  • Coordinating and delivering research in the pandemic: The UK approach

    The acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical research at a time of immense pressure and stress on personnel and resources. It triggered a system-wide response which took the UK’s collaborative culture to new levels. This multi-agency approach enabled unprecedented speed and efficiency in trial […]

  • Why Hospitals Should Act Now to Create Clinical AI Departments

    John Frownfelter, MD, FACP, Chief Medical Information Officer at Jvion A century ago, X-rays transformed medicine forever. For the first time, doctors could see inside the human body, without invasive surgeries. The technology was so revolutionary that in the last 100 years, radiology departments have become a staple of modern hospitals, routinely used across medical […]

  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021

    As we close out the year, we asked several healthcare executives to share their predictions and trends for 2021. Kimberly Powell, Vice President & General Manager, NVIDIA Healthcare Federated Learning: The clinical community will increase their use of federated learning approaches to build robust AI models across various institutions, geographies, patient demographics, and medical scanners. The sensitivity and […]

  • M&A: Philips Acquires Remote Cardiac Monitoring BioTelemetry for $2.8B

    What You Should Know: – Philips acquires BioTelemetry, a U.S. provider of remote cardiac diagnostics and monitoring for $72.00 per share for an implied enterprise value of $2.8 billion (approx. EUR 2.3 billion). – With $439M in revenue in 2019, BioTelemetry annually monitors over 1 million cardiac patients remotely; its portfolio includes wearable heart monitors, […]

  • M&A: Cerner to Acquire Health Division of Kantar for $375M in Cash

    What You Should Know:  – Cerner announces it will acquire Kantar Health, a leading data, analytics, and real-world evidence and commercial research consultancy serving the life science and health care industry. – This acquisition is expected to allow Cerner’s Learning Health Network client consortium and health systems with more opportunities to directly engage with life […]

  • Cerner Invests in Elligo to Make Clinical Trials Accessible for Health Systems of All Sizes

    What You Should Know: – Cerner announced a strategic investment in Elligo Health Research, a leading research organization that enables clinical trials with nationwide community-based health care practices. – Cerner plans to expand the data and tools available in the Cerner Learning Health Network to offer additional clinical trial resources to community and rural hospitals […]

  • Medidata Acquires Digital Biomarker Business of MC10 / Clinical Trials & Wearable Sensors

    What You Should Know: – Clinical trials technology company Medidata has acquired the digital biomarker business of MC10. – MC10’s offerings will bring novel clinical analytics and biosensor capabilities to Medidata’s existing technology solutions, enhancing Medidata’s capabilities to integrate data from wearable sensors – including clinical grade metrics – in clinical trials. – With this […]

  • Intermountain, Sanford Health Signs Intent to Merge

    What You Should Know: – Intermountain Healthcare and Sanford Health sign a letter of intent to merge that will created a combined health system employing more than 89k people at 70 hospitals and 435 clinics across seven states. Intermountain Healthcare and Sanford Health, one of the nation’s leading systems in rural health care delivery and […]

  • Castor Raises $12M to Advance COVID-19 Research Through Clinical Trial and Data Automation

    What You Should Know: – Castor raises $12M in Series A funding to further their support for COVID-19 research through clinical trial and data automation. – With 4,000 live studies and 2,000,000 enrolled patients across 90 countries, Castor will use the funding to further invest in enabling patient-centric, data-powered clinical trials. Castor, a Hoboken, New […]

  • Decentralised trials – aided by tech – could boost clinical research

    Bringing clinical trials to patients – rather than the reverse – could be the key to improving recruitment into studies and making them faster, cheaper and more likely to succeed, according to one clinical research organisation (CRO). There’s already plenty of support from regulators for virtual or ‘decentralised’ trials, including from former FDA Commissioner Scott […]

  • Ciox Health Acquires Biomedical NLP Company Medal

    What You Should Know: – Ciox Health has acquired Medal, Inc., a biomedical Natural Language Processing (biomed-NLP) technology company. – The acquisition will lead Ciox to better and more quickly enable real-world data in support of research that advances patient care. Ciox Health, a leading health technology company, today announced its acquisition of San Francisco-based biomedical Natural Language […]

  • 10 Healthcare Innovations That Can Reduce Total Disease Burden 6-10% by 2040

    What You Should Know: –  40 percent of the global disease burden could be addressed with known interventions, but that leaves 60 percent unaddressed. – As part of the recent McKinsey report Prioritizing health: A prescription for prosperity, the McKinsey Global Institute identified ten promising innovations that can reduce total disease burden 6-10% by 2040. […]